AIC
AYTU icon

AWM Investment Company’s AYTU BioPharma AYTU Stock Holding History

AWM Investment Company’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Hold
619,574
– – 0.19% 80
2025
Q4 		$1.61M Hold
619,574
– – 0.16% 91
2025
Q3 		$1.16M Sell
619,574
-300
-0% -$693 0.11% 90
2025
Q2 		$1.35M Buy
+619,874
New +$963K 0.15% 84

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

AWM Investment Company's AYTU Position: Q1 2026 in Review

AWM Investment Company held its AYTU BioPharma (AYTU) position steady in Q1 2026 at 619,574 shares worth $1.69M. The position accounts for 0.19% of the portfolio, ranked #80.

AWM Investment Company first reported a position in AYTU in Q2 2025 and has held it in 4 quarters since. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • AWM Investment Company held 619,574 shares of AYTU BioPharma worth $1.69M as of Q1 2026.
  • AWM Investment Company left its AYTU BioPharma share count unchanged in Q1 2026.
  • AYTU BioPharma made up 0.19% of AWM Investment Company's portfolio in Q1 2026, its #80 holding.
  • AWM Investment Company first reported a position in AYTU BioPharma in Q2 2025 and has held it in 4 quarters since.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.